Nirmatrelvir/Ritonavir for hemodialysis patients with COVID-19

Background: Hemodialysis patients have a high risk of severe/critical COVID-19 and related high mortality, but nirmatrelvir/ritonavir is not recommended for hemodialysis patients with COVID-19 infection because of lack of evidence of safety. Objectives: Our study aims to evaluate the minimum plasma...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Jiayue, Cai, Hong, Hao, Yujun, Lin, Zhang, Liu, Shang, Zhan, Yaping, Ding, Li, Huang, Meilan, Li, Zhenyuan, Xu, Lan, Yan, Xiujuan, Yang, Li, Zhang, He, Zhang, Wei, Zhao, Li, Zhao, Junli, Wang, Ting, Gu, Leyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213535/
https://www.ncbi.nlm.nih.gov/pubmed/37251313
http://dx.doi.org/10.3389/fphar.2023.1161897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213535/
https://www.ncbi.nlm.nih.gov/pubmed/37251313
http://dx.doi.org/10.3389/fphar.2023.1161897

Ejemplares similares